Literature DB >> 11530355

Models for the population biology and control of human onchocerciasis.

M G Basáñez1, J Ricárdez-Esquinca.   

Abstract

The absence of animal models in which to reproduce successfully the complete life cycle of Onchocerca volvulus has hindered progress towards unravelling the processes involved in the regulation of parasite abundance in the vertebrate host. Mathematical frameworks have been developed to explore the consequences of such processes in determining parasite population dynamics and the effect on these of control interventions. Post-control predictions are strongly influenced by the assumptions concerning the reproductive life span of the adult female worm (the longest-lived parasite stage) and the distribution of its survival times, and this notion is important to all frameworks. Here, we review the development of models concerning onchocerciasis and discuss the various approaches that have been used, presenting a deterministic framework with parameter values estimated from the Mexican onchocerciasis control programme. This model is used to evaluate interventions combining the removal of adult worms (nodulectomy) and the microfilaricidal and possibly sterilizing effect of ivermectin.

Entities:  

Mesh:

Year:  2001        PMID: 11530355     DOI: 10.1016/s1471-4922(01)02013-x

Source DB:  PubMed          Journal:  Trends Parasitol        ISSN: 1471-4922


  14 in total

1.  Modeling targeted ivermectin treatment for controlling river blindness.

Authors:  Eric M Poolman; Alison P Galvani
Journal:  Am J Trop Med Hyg       Date:  2006-11       Impact factor: 2.345

Review 2.  Modeling and biological control of mosquitoes.

Authors:  Cynthia C Lord
Journal:  J Am Mosq Control Assoc       Date:  2007       Impact factor: 0.917

Review 3.  A research agenda for helminth diseases of humans: modelling for control and elimination.

Authors:  María-Gloria Basáñez; James S McCarthy; Michael D French; Guo-Jing Yang; Martin Walker; Manoj Gambhir; Roger K Prichard; Thomas S Churcher
Journal:  PLoS Negl Trop Dis       Date:  2012-04-24

4.  River blindness: a success story under threat?

Authors:  María-Gloria Basáñez; Sébastien D S Pion; Thomas S Churcher; Lutz P Breitling; Mark P Little; Michel Boussinesq
Journal:  PLoS Med       Date:  2006-09       Impact factor: 11.069

5.  Macrofilaricides and onchocerciasis control, mathematical modelling of the prospects for elimination.

Authors:  W S Alley; G J van Oortmarssen; B A Boatin; N J Nagelkerke; A P Plaisier; J H Remme; J Lazdins; G J Borsboom; J D Habbema
Journal:  BMC Public Health       Date:  2001-11-06       Impact factor: 3.295

6.  Uncertainty surrounding projections of the long-term impact of ivermectin treatment on human onchocerciasis.

Authors:  Hugo C Turner; Thomas S Churcher; Martin Walker; Mike Y Osei-Atweneboana; Roger K Prichard; María-Gloria Basáñez
Journal:  PLoS Negl Trop Dis       Date:  2013-04-25

7.  Time series analysis of onchocerciasis data from Mexico: a trend towards elimination.

Authors:  Edgar E Lara-Ramírez; Mario A Rodríguez-Pérez; Miguel A Pérez-Rodríguez; Monsuru A Adeleke; María E Orozco-Algarra; Juan I Arrendondo-Jiménez; Xianwu Guo
Journal:  PLoS Negl Trop Dis       Date:  2013-02-14

8.  Contribution of migrant coffee labourers infected with Onchocerca volvulus to the maintenance of the microfilarial reservoir in an ivermectin-treated area of Mexico.

Authors:  Mario A Rodríguez-Pérez; Aldo Segura Cabrera; Cristian Lizarazo Ortega; María-Gloria Basáñez; John B Davies
Journal:  Filaria J       Date:  2007-12-18

9.  A repurposing strategy for Hsp90 inhibitors demonstrates their potency against filarial nematodes.

Authors:  Victoria Gillan; Kerry O'Neill; Kirsty Maitland; Francis M Sverdrup; Eileen Devaney
Journal:  PLoS Negl Trop Dis       Date:  2014-02-13

10.  Modelling parasite transmission in a grazing system: the importance of host behaviour and immunity.

Authors:  Naomi J Fox; Glenn Marion; Ross S Davidson; Piran C L White; Michael R Hutchings
Journal:  PLoS One       Date:  2013-11-06       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.